Vancouver, British Columbia - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ('Emerald') announced that Avtar Dhillon, MD, has resigned from his roles as director and Executive Chairman of Emerald's board of directors for personal reasons effective immediately. 'We would like to thank Dr. Dhillon for his significant contributions to the building of Emerald and wish him all the best in his future endeavors,' said Jim Heppell, incoming Chairman of Emerald's board of directors.

About Emerald Health Therapeutics, Inc.

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products, with an emphasis on science-based innovation and product excellence.

Contact:

Jenn Hepburn

Chief Financial Officer

T: 1(800) 757 3536 Ext. #5

Emerald Investor

T: (800) 757 3536 Ext. #5

E: invest@emeraldhealth.ca

(C) 2021 Electronic News Publishing, source ENP Newswire